Posted in | News | Nanoanalysis

250 Peer-Reviewed Publications Feature Nanosight Technology

June 2011 has seen the total number of peer-reviewed user publications featuring Nanosight's Nanoparticle Tracking Analysis (NTA) and citations reach 250. This number has been rising rapidly with the most recent 150 papers appearing in less than a year. Starting with this issue of NanoTrail, we will be highlighting three papers and providing links to where you may view them in more detail.

As NanoSight founder and CTO, Bob Carr, says, third party papers is the best proof for a new method being accepted by the world at large. Our long list which has been generated so rapidly provides maximum credibility and widespread international endorsement of our technology.

The full list will continue to be updated on our web site where the papers are grouped by application: toxicity & the environment, assessment of NTA, drug delivery & micelles, exosomes, pharma & vaccines, nanoparticle production and materials/miscellaneous. The link is here.

Here are soem examples of research people are doing using the NTA.

  1. Cheska Gillespie, Peter Halling and Darren Edwards (2011)
    Monitoring of particle growth at a low concentration of a poorly water soluble drug using the NanoSight LM20, Colloids and Surfaces A: Physicochemical and Engineering Aspects, Article in Press, doi:10.1016/j.colsurfa.2011.03.052
  2. Ye Li, Vassiliy Lubchenko, and Peter G. Vekilov (2011)
    The use of dynamic light scattering and Brownian microscopy to characterize protein aggregation, Rev. Sci. Instrum. 82, 053106 (2011); doi:10.1063/1.3592581
  3. Julian A. Gallego-Urrea, Jani Tuoriniemi and Martin Hassellöv (2011)
    Applications of particle-tracking analysis to the determination of size distributions and concentrations of nanoparticles in environmental, biological and food samples, TrAC Trends in Analytical Chemistry, Volume 30, Issue 3, Pages 473-483 (8th paper)

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.